Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 28 Neoplasm Metastasis 6 Recurrence 5 Breast Neoplasms 4 Stomach Neoplasms 3 Prostate Cancer Metastatic 3 Neoplastic Cells, Circulating 3 Carcinoma, Transitional Cell 3 Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer, Hereditary, 7 1 Penile Neoplasms 1 Nonseminomatous germ cell tumor 1 Metastatic Castration-resistant Prostate Cancer, MCRPC 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Breast Cancer With Intracranial Metastases 1 Lung Neoplasms 1 Liposarcoma 1 Hormone-Resistant Prostate Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Diarrhea 1 Colorectal Neoplasms 1 Castrate-resistant Metastatic Prostate Cancer 1

Interventions

Cisplatin 113 Radiotherapy 71 Cetuximab 68 Docetaxel 50 Paclitaxel 41 pembrolizumab 39 Carboplatin 39 Fluorouracil 38 Radiotherapy, Intensity-Modulated 30 Drug Therapy 15 Radiation 13 Gefitinib 13 Nivolumab 11 Gemcitabine 11 Surgical Procedures, Operative 10 Bevacizumab 10 Amifostine 9 tislelizumab 8 Pemetrexed 8 Oxaliplatin 8 Erlotinib Hydrochloride 8 Celecoxib 8 Capecitabine 8 durvalumab 7 atezolizumab 7 Filgrastim 7 Panitumumab 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01620242 2021-03-02

ORL03

UNICANCER

Phase 2 Completed

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡